European Journal of Biomedical and Pharmaceutical Sciences

STANDARDIZATION OF MARKETED POLYHERBAL CHURNA

Snehal S. Manekar*, Darshan P. Muley and Ankur P. Patode

ABSTRACT

The therapeutic potential of ethno medicinal plants has been studied for several years. Over the years, many ailments have been cured with herbal remedies. Due to the enormous range of therapeutically important secondary metabolites in plants, which are natural products, they are also important sources of novel medications. At specific concentrations of their chemical components, drugs or formulations are anticipated to exert the intended biological action. Standardization is a crucial stage in formulation since it affects the product's quality. Drugs or formulations are expected to exert a desired biological activity at particular concentrations of their chemical constituents. The overall aim of drug standardization is to ensure the quality, efficacy and uniformity of the products, in terms of their chemical and biological properties, across the manufactures. It is important to create a methodology for standardising every product sold on the market to prevent variance from occurring from batch to batch. Plant materials differ from synthetic medications in numerous ways, including their chemical composition, depending on the time, year they are collected, where they are grown, and other factors. The goal of the present effort is to offer standardization of marketed polyherbal churna Pet saffa. The churna was purchased and processed to standardisation for factors including organoleptic characteristics, physical characteristics, and physiochemical properties and heavy metal detection. According to the findings, they complied with the standard readings.

Keywords: Polyherbal, standardization, churna, physicochemical parameters.